Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 study

202060 citationsJournal Articlehybrid Open Access

Authors

NCT02743221 (ClinicalTrials.gov).

Good health and well-being

Published in: Annals of Oncology

Volume 31, Issue 9, pp. 1160-1168

Field-Weighted Citation Impact: 3.68